| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10549-013-2558-2 |
| P698 | PubMed publication ID | 23670131 |
| P50 | author | Michael Hauptmann | Q56556533 |
| Esther H Lips | Q95840560 | ||
| P2093 | author name string | Petra M Nederlof | |
| Jelle Wesseling | |||
| Lodewyk F A Wessels | |||
| Sabine C Linn | |||
| Jorma J de Ronde | |||
| Philip C Schouten | |||
| Ewald van Dyk | |||
| Laura Holtman | |||
| Lennart Mulder | |||
| Linde M Braaf | |||
| P2860 | cites work | Diagnosis of multiple cancer types by shrunken centroids of gene expression | Q29615528 |
| The pitfalls of platform comparison: DNA copy number array technologies assessed | Q30967336 | ||
| A faster circular binary segmentation algorithm for the analysis of array CGH data | Q31094033 | ||
| A modified Bayes information criterion with applications to the analysis of comparative genomic hybridization data | Q31109925 | ||
| Clinical trial designs for predictive marker validation in cancer treatment trials | Q33213015 | ||
| A new look towards BAC-based array CGH through a comprehensive comparison with oligo-based array CGH. | Q33280495 | ||
| Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors | Q33358940 | ||
| KC-SMARTR: An R package for detection of statistically significant aberrations in multi-experiment aCGH data. | Q33744507 | ||
| Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement | Q34820314 | ||
| An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients | Q35064705 | ||
| Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction | Q35558070 | ||
| The genetic epidemiology of breast cancer genes | Q35959353 | ||
| Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies | Q37099938 | ||
| Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment | Q37309421 | ||
| Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers | Q37933098 | ||
| Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy? | Q38028797 | ||
| CGH arrays compared for DNA isolated from formalin-fixed, paraffin-embedded material | Q38406502 | ||
| Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens | Q38416233 | ||
| Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors | Q40238953 | ||
| High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer. | Q42163493 | ||
| Breast cancer molecular profiling with single sample predictors: a retrospective analysis | Q42467730 | ||
| Genomic signature of BRCA1 deficiency in sporadic basal‐like breast tumors | Q42480299 | ||
| Joint segmentation, calling, and normalization of multiple CGH profiles | Q43461837 | ||
| REporting recommendations for tumor MARKer prognostic studies (REMARK). | Q46099462 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 317-327 | |
| P577 | publication date | 2013-05-14 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Platform comparisons for identification of breast cancers with a BRCA-like copy number profile | |
| P478 | volume | 139 |
| Q40870110 | BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial |
| Q40907759 | BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential |
| Q40556065 | Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2-like male breast cancer |
| Q27006938 | Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers |
| Q33988970 | Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases |
| Q36087198 | Levels of DNA Methylation Vary at CpG Sites across the BRCA1 Promoter, and Differ According to Triple Negative and "BRCA-Like" Status, in Both Blood and Tumour DNA. |
| Q41136344 | Proper genomic profiling of (BRCA1-mutated) basal-like breast carcinomas requires prior removal of tumor infiltrating lymphocytes. |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q41136538 | Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms |
| Q41542872 | The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting. |
| Q38607861 | The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer. |
Search more.